Marius Cristian Marinaș

Dr. Marius Cristian Marinaș


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
LTLavinia Toma-Tumbar
Lavinia Toma-Tumbar
RNRodica Nagy
Rodica Nagy
MMMarius Cristian Marinaș
Marius Cristian Marinaș
Dominic Gabriel IliescuDominic Gabriel Iliescu
Dominic Gabriel Iliescu
MCMonica Laura Cara
Monica Laura Cara
This narrative review delves into the multifaceted landscape of obstetric and gynecological malpractice, focusing on stakeholders’ expectations, legal implications, and clinical considerations. Through a comprehensive analysis of the relevant literature, we evaluated 25 articles, culminating in a comprehensive understanding of the primary drivers behind malpractice litigation in this field. The review highlights the complex nature of these issues and their implications for various stakeholders. The key findings reveal the critical role of meeting medical care standards to avoid harm to patients, along with factors such as diagnostic errors, mismanagement of complications, and deficiencies in patient counseling contributing to malpractice allegations. Additionally, issues related to surgical procedures, informed consent, and documentation are explored. The review underscores the importance of collaboration, education, and accountability in mitigating the impact of malpractice and upholding patient safety in obstetric and gynecological practice.

11 November 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
Vlad PadureanuVlad Padureanu
Vlad Padureanu
Virginia Maria RadulescuVirginia Maria Radulescu
Virginia Maria Radulescu
CMCristiana Moise
Cristiana Moise
MMMarius Cristian Marinaș
Marius Cristian Marinaș
Padureanu RodicaPadureanu Rodica
Padureanu Rodica
BLBOLDEANU LIDIA
BOLDEANU LIDIA
Background/Objectives: Oxidative stress contributes to the pathogenesis of cirrhosis, but its value as a clinical biomarker remains uncertain. Methods: We retrospectively analysed 90 patients with decompensated cirrhosis. Serum malondialdehyde (MDA) and 8-epi-prostaglandin F2α (8-iso-PGF2α) were measured at admission. Biomarker levels were compared between Child–Pugh classes B and C, across hepatic encephalopathy grades, and ascites severity, using Mann–Whitney, Kruskal–Wallis, and Spearman correlation tests. Results: Median MDA did not differ significantly between Child–Pugh classes B and C (2.67 [2.10–3.20] vs. 2.45 [1.98–3.05] μmol/L; p = 0.331), nor across ascites categories (p = 0.453). Similarly, 8-iso-PGF2α values did not vary between Child–Pugh classes (255.8 [220.0–310.0] vs. 250.1 [210.0–295.0] pg/mL; p = 0.784) or ascites groups (p = 0.828). Spearman analysis showed no significant correlations with albumin, INR, bilirubin, creatinine, or age, except for a non-significant trend with bilirubin (ρ = −0.18, p = 0.09). Importantly, MDA levels increased significantly across encephalopathy grades (p = 0.021), suggesting a link between systemic oxidative stress and neuropsychiatric impairment. Conclusions: In this clinical cohort, oxidative stress biomarkers did not provide discriminatory value for staging by Child–Pugh or ascites, but MDA was associated with encephalopathy severity. These findings highlight both the limitations and potential clinical relevance of oxidative stress markers in cirrhosis management.

29 October 2025 in Life
Verified
Journal Article
Open access
PDF file
TTTiberiu Stefanita Tenea-Cojan
Tiberiu Stefanita Tenea-Cojan
VSValeriu Marin Surlin
Valeriu Marin Surlin
SMStelian Stefanita Mogoanta
Stelian Stefanita Mogoanta
NMNicolae Dragos Margaritescu
Nicolae Dragos Margaritescu
Daniel Cosmin CarageaDaniel Cosmin Caragea
Daniel Cosmin Caragea
LBLAURENTIU Augustus BARBU
LAURENTIU Augustus BARBU
Background: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with poor prognosis, most frequently metastasizing to the liver, peritoneum, and lungs. Intestinal metastases are exceptionally rare and easily misinterpreted as primary small-bowel tumors, typically presenting with acute complications such as obstruction, perforation, or bleeding. Methods: We combined a detailed case description with a narrative literature review. PubMed/MEDLINE and Embase (2000–2025) were searched for case reports and case series describing intestinal metastases from PDAC with histopathological and immunohistochemical confirmation. Case presentation: We report a female patient presenting with acute intestinal obstruction caused by a synchronous ileal metastasis from PDAC. Imaging revealed an ileal stenosing lesion and a pancreatic body mass. An exploratory laparotomy identified a 3 cm transmural ileal tumor with additional serosal nodules. Histopathology confirmed a moderately differentiated adenocarcinoma. Immunohistochemistry supported pancreatic origin (CK7+, CA19-9+, faint CDX2), with mutant-type p53 positivity, ultra-low HER2/Neu expression, and a Ki-67 index of ~50%. The patient underwent segmental enterectomy with terminal ileostomy, followed by systemic therapy. Conclusions: This represents an exceptional and rare clinical finding rather than a presentation from which broad conclusions can be drawn. Histopathological and immunohistochemical analysis supported pancreatic origin and helped avoid misclassification as a primary intestinal neoplasm. It underscores the importance of careful clinicopathological correlation and multidisciplinary evaluation in atypical metastatic scenarios, while illustrating how surgery can provide symptom control and enable systemic therapy. Given its rarity, these observations should be interpreted with caution and regarded as descriptive rather than generalizable.